Remove Healthcare Remove M&A Remove Mergers and Acquisitions
article thumbnail

Healthcare Trends & Transactions Q1 2025

JD Supra: Mergers

The healthcare mergers and acquisitions (M&A) market began 2025 with a slower start than expected given the easing headwinds and building momentum at the end of last year, with the number of deals reported in Q1 lower than the number of deals reported in the same period last year.

article thumbnail

Emerging Trends in Healthcare Mergers & Acquisition

JD Supra: Mergers

The healthcare industry is no stranger to mergers and acquisitions (M&A). Over the years, consolidation has played a significant role in reshaping the healthcare landscape, driven by factors such as regulatory changes, technological advancements, and the pursuit of economies of scale. By: Ankura

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2024 Predictions: Unveiling the future of healthcare mergers and acquisitions

JD Supra: Mergers

Today, a tale of two markets are seen in healthcare mergers and acquisition (M&A): the present (as reflected in the data about declining dealmaking) and the future (reflected in the increasingly positive outlook by dealmakers). By: Foley & Lardner LLP

article thumbnail

Prepare To Be Under the Microscope: Transaction Review Laws in Healthcare and Private Equity M&A

JD Supra: Mergers

A recent wave of state legislation is changing the course of healthcare transactions, and organizations (particularly private equity-backed organizations) that engage in mergers and acquisitions in the healthcare industry should prepare for increased scrutiny. By: BakerHostetler

article thumbnail

Healthcare Trends & Transactions Q3 2024

JD Supra: Mergers

In the healthcare mergers and acquisitions (M&A) market, while deal volumes varied across different sectors, by and large the sure and steady pace of deal volume in Q2 continued into Q3.

article thumbnail

Honesty is the Best Policy: Navigating the DOJ’s M&A Safe Harbor

JD Supra: Mergers

The recent announcement of the Department of Justices (DOJ) M&A Safe Harbor policy has significant implications for companies involved in mergers and acquisitions (M&A) within the healthcare industry. By: Gardner Law

M&A 159
article thumbnail

Beyond Paperwork: Assessing the Effectiveness of a Compliance Program

JD Supra: Mergers

It is a critical aspect that can significantly impact mergers and acquisitions (M&A) and the overall success of your business. In this alert, we delve into the importance of healthcare compliance in M&A for FDA-regulated companies and provide key insights on evaluating the effectiveness of a compliance program.